Publications by authors named "Tetsuya Taura"

Claim this Profile
D
Development of DPP-4-resistant CXCL9-Fc and CXCL10-Fc chemokines for effective cancer immunotherapy.
Jennie Lugassy, Noor Abdala-Saleh, Ghada Jarrous, Abeer Turky, Daniel Saidemberg, Tetsuya Taura

Proc Natl Acad Sci U S A· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 and CTLA-4 serve as major gatekeepers for effector and cytotoxic T-cell potentiation by limiting a CXCL9/10-CXCR3-IFNγ positive feedback loop.
Noor Abdala-Saleh, Jennie Lugassy, Akshatha Shivakumar-Kalvhati, Abeer Turky, Sari Abu Ras, Tetsuya Taura

Front Immunol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modifying antibody-FcRn interactions to increase the transport of antibodies through the blood-brain barrier.
Jason Tien, Dmitri Leonoudakis, Ralitsa Petrova, Vivian Trinh, Tetsuya Taura

MAbs· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Migraine therapeutics differentially modulate the CGRP pathway.
Minoti Bhakta, Trang Vuong, Tetsuya Taura, David S Wilson, Jennifer R Stratton

Cephalalgia· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity.
Sarah L Pogue, Tetsuya Taura, Mingying Bi, Yong Yun, Angela Sho

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis